Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression

Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression

Abstract Background Besides providing reassurance about cardiovascular (CV) safety of newer diabetes drugs, cardiovascular outcome trials (CVOTs) have also shown encouraging benefits on some CV endpoints. The contribution of the better glycemic control in the reduction of major cardiovascular events...

Full description

Bibliographic Details
Main Authors: Maria Ida Maiorino, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Paolo Chiodini, Katherine Esposito, Dario Giugliano
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular outcome trials
Type 2 diabetes
DPP-4i
GLP-1RA
SGLT-2i
Cardiorenal outcomes
Online Access:https://doi.org/10.1186/s12933-021-01401-8

Internet

https://doi.org/10.1186/s12933-021-01401-8

Similar Items